__timestamp | Agios Pharmaceuticals, Inc. | Opthea Limited |
---|---|---|
Wednesday, January 1, 2014 | 100371000 | 3401685 |
Thursday, January 1, 2015 | 141827000 | 4284228 |
Friday, January 1, 2016 | 220163000 | 3581295 |
Sunday, January 1, 2017 | 292681000 | 4838300 |
Monday, January 1, 2018 | 341324000 | 24891534 |
Tuesday, January 1, 2019 | 410894000 | 31347891 |
Wednesday, January 1, 2020 | 367470000 | 17480747 |
Friday, January 1, 2021 | 256973000 | 34710152 |
Saturday, January 1, 2022 | 279910000 | 108459978 |
Sunday, January 1, 2023 | 288903000 | 181563523 |
Monday, January 1, 2024 | 301286000 | 176326321 |
Data in motion
In the competitive world of biotechnology, innovation is the lifeblood of success. Agios Pharmaceuticals, Inc. and Opthea Limited are two companies that exemplify this drive. Over the past decade, Agios has consistently outpaced Opthea in research and development (R&D) spending, investing nearly five times more on average. However, the gap has been narrowing. In 2023, Opthea's R&D expenses surged to 63% of Agios's, a significant leap from just 3% in 2014. This trend suggests a strategic pivot by Opthea towards more aggressive innovation. While Agios's investment peaked in 2019, Opthea's spending has shown a steady upward trajectory, indicating a potential shift in the innovation landscape. As we look to the future, the question remains: will Opthea's increased investment translate into groundbreaking advancements, or will Agios maintain its lead in the innovation race?
Johnson & Johnson or Opthea Limited: Who Invests More in Innovation?
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Biogen Inc. and Opthea Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
Exelixis, Inc. or Opthea Limited: Who Invests More in Innovation?
Research and Development Investment: Opthea Limited vs Geron Corporation
Analyzing R&D Budgets: Opthea Limited vs Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Agios Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Perrigo Company plc and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Protagonist Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and Xencor, Inc.